Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Miles, J.M.
Right arrow Articles by Haymond, M.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miles, J.M.
Right arrow Articles by Haymond, M.W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Metabolic and Neurologic Effects of an Intravenous Medium-Chain Triglyceride Emulsion

J.M. Miles, M.D.

Endocrine Research Unit, Departments of Medicine, Pediatrics, Pathology, Neurology, and Neurosurgery, Mayo Medical School, Rochester, Minnesota

M. Cattalini, M.D.

Endocrine Research Unit, Departments of Medicine, Pediatrics, Pathology, Neurology, and Neurosurgery, Mayo Medical School, Rochester, Minnesota

F.W. Sharbrough, M.D.

Endocrine Research Unit, Departments of Medicine, Pediatrics, Pathology, Neurology, and Neurosurgery, Mayo Medical School, Rochester, Minnesota

L.E. Wold, M.D.

Endocrine Research Unit, Departments of Medicine, Pediatrics, Pathology, Neurology, and Neurosurgery, Mayo Medical School, Rochester, Minnesota

R.E. Wharen, JR, M.D.

Endocrine Research Unit, Departments of Medicine, Pediatrics, Pathology, Neurology, and Neurosurgery, Mayo Medical School, Rochester, Minnesota

J.E. Gerich, M.D.

Endocrine Research Unit, Departments of Medicine, Pediatrics, Pathology, Neurology, and Neurosurgery, Mayo Medical School, Rochester, Minnesota

M.W. Haymond, M.D.

Endocrine Research Unit, Departments of Medicine, Pediatrics, Pathology, Neurology, and Neurosurgery, Mayo Medical School, Rochester, Minnesota

These studies were undertaken to investigate the relationship between medium-chain fatty acid availability, medium-chain fatty acid oxidation, and central nervous system toxicity during infusion of medium-chain triglycerides in dogs. Six dogs received a sequential, stepwise infusion of trioctanoin at three different rates for 80 min each, providing calories below and equal to resting energy expenditure in the species. Ketone body production rates (using a 14C β-hydroxybutyrate tracer) and plasma concentrations of lactate and octanoate were monitored. Three animals were infused with saline to serve as controls. Blood-brain barrier integrity was assessed with Evans blue dye, and brain samples were taken at the end of the study to quantify brain water. Three animals were studied under anesthesia to obtain good quality EEG and intracranial pressure measurements. Results were (1) plasma octanoate increased to 0.37 ± 0.13, 0.78 ± 0.2, and 1.44 ± 0.41 mmol/liter during the three infusion intervals; (2)emesis, somnolence, and coma were observed at the two highest trioctanoin rates; (3)ketone body concentrations and production increased from 102 ± 15 to 859 ± 54 µmol/liter and 3.6 ± 0.43 to 18.5 ± 1.7 µmol/kg/min, respectively, at the highest trioctanoin infusion rate; and (4)plasma lactate also increased from 1.3 ± 0.1 to 4.3 ± 0.9 mmol/liter at the highest infusion rate. EEG changes were also observed, consisting of high amplitude slowing and reduction in amplitude of faster components. There was no extravasation of Evans blue dye, nor change in brain water or intracranial pressure. The conclusion—medium—chain triglycerides have significant dose-related central nervous system toxicity in dogs. Therefore, caution should be exercised in clinical studies with MCTs, including careful measurement of medium-chain fatty acid concentrations. (Journal of Parenteral and Enteral Nutrition 15:37-41, 1991)

Journal of Parenteral and Enteral Nutrition, Vol. 15, No. 1, 37-41 (1991)
DOI: 10.1177/014860719101500137


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
International Journal of ToxicologyHome page
Caprylic/Capric Triglyceride
International Journal of Toxicology, January 1, 2003; 22(1_suppl): 4 - 5.
[PDF]


Home page
J. Nutr.Home page
J. Han, S. R. Farmer, J. L. Kirkland, B. E. Corkey, R. Yoon, T. Pirtskhalava, Y. Ido, and W. Guo
Octanoate Attenuates Adipogenesis in 3T3-L1 Preadipocytes
J. Nutr., May 1, 2002; 132(5): 904 - 910.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. U. Weigt, M. Georgieff, C. Beyer, and K. J. Fohr
Activation of Neuronal N-Methyl-D-Aspartate Receptor Channels by Lipid Emulsions
Anesth. Analg., February 1, 2002; 94(2): 331 - 337.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
J. W. Kruimel, T. H. Naber, J. Adam van der Vliet, C. Carneheim, M. B. Katan, and J. B. Jansen
Parenteral Structured Triglyceride Emulsion Improves Nitrogen Balance and Is Cleared Faster from the Blood in Moderately Catabolic Patients
JPEN J Parenter Enteral Nutr, September 1, 2001; 25(5): 237 - 244.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
J. W. Kruimel, A. H. Naber, J. H. Curfs, M. A. Wenker, and J. B. Jansen
With Medium-Chain Triglycerides, Higher and Faster Oxygen Radical Production by Stimulated Polymorphonuclear Leukocytes Occurs
JPEN J Parenter Enteral Nutr, March 1, 2000; 24(2): 107 - 112.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
R. Bellantone, M. Bossola, C. Carriero, M. Malerba, P. Nucera, C. Ratto, P. Crucitti, F. Pacelli, G. Battista Doglietto, and F. Crucitti
Structured Versus Long-Chain Triglycerides: A Safety, Tolerance, and Efficacy Randomized Study in Colorectal Surgical Patients
JPEN J Parenter Enteral Nutr, May 1, 1999; 23(3): 123 - 127.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
R. Sandstrom, A. Hyltander, U. Korner, and K. Lundholm
Structured Triglycerides Were Well Tolerated and Induced Increased Whole Body Fat Oxidation Compared With Long-Chain Triglycerides in Postoperative Patients
JPEN J Parenter Enteral Nutr, September 1, 1995; 19(5): 381 - 386.
[Abstract] [PDF]


Home page
Nutr Clin PractHome page
A. Hyltander, R. Sandstrom, and K. Lundholm
Invited Review: Metabolic Effects of Structured Triglycerides in Humans
Nutr Clin Pract, June 1, 1995; 10(3): 91 - 97.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
S. Klein and J. M. Miles
Metabolic Effects of Long-Chain and Medium-Chain Triglyceride Emulsions in Humans
JPEN J Parenter Enteral Nutr, September 1, 1994; 18(5): 396 - 397.
[PDF]


Home page
JPEN J Parenter Enteral NutrHome page
J. Linseisen and G. Wolfram
Odd-Numbered Medium-Chain Triglycerides (Trinonanoin) in Total Parenteral Nutrition: Effects on Parameters of Fat Metabolism in Rabbits
JPEN J Parenter Enteral Nutr, November 1, 1993; 17(6): 522 - 528.
[Abstract] [PDF]


Home page
Nutr Clin PractHome page
M. M. Gottschlich
Invited Review: Selection of Optimal Lipid Sources in Enteral and Parenteral Nutrition
Nutr Clin Pract, August 1, 1992; 7(4): 152 - 165.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
J.W. Bailey, M.W. Haymond, and J.M. Miles
Triacetin: A Potential Parenteral Nutrient
JPEN J Parenter Enteral Nutr, January 1, 1991; 15(1): 32 - 36.
[Abstract] [PDF]